Pirouette Pharma
YC S21Boston, US · Founded 2017 · 9 employees · 2 known investors
Pirouette develops OnePush, a fully automatic hidden-needle auto-injector platform paired with drug programs across chronic and rescue care indications. The company is advancing clinical-stage programs in naloxone, epinephrine, promethazine, and methotrexate while scaling U.S. automated manufacturing and securing IP protection through 2045.
Advanced ManufacturingBiotechHealthtechMedical DevicesHealth TechHealthcarein /pirouettepharma@pirouettepharma
Founders & leadership· Y Combinator alumni (S21)
Investors · 2
In the news
- Pirouette Pharma on Wefunder 2026 - Kingscrowdkingscrowd.com · 2026
- Pirouette Pharma - 2026 Company Profile, Funding & Competitors - Tracxntracxn.com · 2025
- Pirouette Pharma Secures $7.7M to Make Injections as Easy as Pushing a Button | SignalBasetrysignalbase.com · 2025
- Pirouette Medical’s auto-injector wins 2024 Product of the Year - NH Business Reviewnhbr.com · 2024
- Safar Partners Leads Pirouette’s Investment Round with $5M+ Raised, Extending Opportunity for Public to Invest Alongside Renowned Investors like Y Combinatorbusinesswire.com · 2024
- Windgap Medical - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Pirouette Pharma Funding | Complete Analysis | Extruct AIextruct.ai